Documents
In this section, you will find reviews and digests regarding the status of antiviral research and development on various diseases of interest, along with other types of reports and listings.
To buy a document, click on the corresponding button (following the description). You will be transferred to a secure online PayPal® transaction site for payment through your PayPal® account or credit card. Upon payment, you will receive an email that will provide you with a link to download your document.
Please note that this link is time-sensitive and will expire after 24 h!!!
Documents available below:
1. Companies active in Antivirals 2024
2. Viral Vaccines Based on Viral Expression Vectors 2024
3. Respiratory Syncytial Virus R&D status 2024
4. Zika virus R&D status 2024
5. Chikungunya virus R&D status 2024
6. Dengue virus R&D status 2024
7. Coronaviruses R&D status 2024 (including the new SARS-CoV-2 virus)
8. Ebola and Filoviruses R&D status 2024
9. Norovirus R&D status 2024
10. Published Lead Compounds with Antiviral Activity
- Last update Jan. 2024
- Over 385 companies listed, worldwide distribution
- Running active programs in antiviral drugs and vaccines discovery and development
- Company name, website, physical address, email address, phone/fax numbers, contact names, and virus programs
- Provided as an Excel spreadsheet
- Price: $295 US
- 292 vaccines listed
- Global coverage
- Sponsors/Co-sponsors, Name of vaccine with synonyms, Type of vaccine, Viral vector used, Virus target, Development status
- Includes vaccines at all stages of development
- All types of viral expression systems (MVA, Adeno, AAV, etc.)
- Provides insights into novel approaches and targets
- Future directions and perspectives
- Excel format
- Last update May. 2024
- Price: $325 US
- Last update May. 2024
- 181 products listed, all stages of development
- Over 100 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel document
- Price: $235 US
- Last update Jun. 2024
- 82 products listed, all stages of development
- More than 60 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel document
- Price: $100 US
- Last update Jul. 2024
- 43 products listed, all stages of development
- More than 27 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel spreadsheet
- Price: $100 US
- Last update May. 2024
- 119 products listed, all stages of development
- Over 80 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel document
- Price: $125 US
- Last update Jul. 2024
- 698 products listed (including 608 related to SARS-CoV-2), all stages of development
- Over 250 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel spreadsheet
- Price: $250 US
- Last update May. 2024
- 137 products listed, all stages of development
- More than 73 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel document
- Price: $230 US
- Last update May. 2024
- 21 products listed, all stages of development
- More than 16 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provided as an Excel spreadsheet
- Price: $100 US
- Over 350 lead compounds included, developed against 15 families of Virus and 32 individual viruses
- Excel format with information selected to provide a quick overview of compound's key attributes
- Organizations (originators) and compound’s designation, plus References
- Mechanisms of action when deciphered (including several new targets)
- Activity on viral target and/or virus replication in cell-based assays (IC50, EC50), along with Cytotoxicity
- Classified by target Virus types/Families
- Chemical structures (including several novel drug scaffolds)
- Price: $295 US